Teradyne, Ouster, Serve Robotics, MDA Space, and PROCEPT BioRobotics are the five Robotics stocks to watch today, according to MarketBeat's stock screener tool. Robotics stocks are shares of publicly traded companies that develop, manufacture, or use robots and related technologies, such as automation systems, sensors, and robotics software. For investors, the term can include both specialized robotics firms and larger companies with significant robotics businesses, so exposure and risks vary. These companies had the highest dollar trading volume of any Robotics stocks within the last several days.
Teradyne (TER)
Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
TER traded up $24.38 during trading on Monday, reaching $242.59. 1,770,288 shares of the company were exchanged, compared to its average volume of 3,612,432. Teradyne has a 12-month low of $151.52 and a 12-month high of $487.91. The company's 50-day moving average is $351.61 and its two-hundred day moving average is $348.76. The company has a market cap of $37.87 billion, a price-to-earnings ratio of 27.85, a P/E/G ratio of 0.43 and a beta of 1.73.
Read Our Latest Research Report on TER
Ouster (OUST)
Ouster, Inc. provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in Americas, the Asia-Pacific, Europe, the Middle East, and Africa. Its products include high-resolution scanning and solid-state digital lidar sensors, analog lidar sensors, and software solutions.
Shares of OUST traded up $3.61 during midday trading on Monday, hitting $38.40. 2,265,635 shares of the company traded hands, compared to its average volume of 3,082,529. Ouster has a one year low of $16.40 and a one year high of $63.79. The firm has a market cap of $2.77 billion, a P/E ratio of -55.65 and a beta of 3.47. The stock has a 50-day moving average of $35.36 and a 200-day moving average of $32.54.
Read Our Latest Research Report on OUST
Serve Robotics (SERV)
Serve Robotics Inc. designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. It builds self-driving delivery robots. The company was formerly known as Patricia Acquisition Corp. and changed its name to Serve Robotics Inc. in July 2023.
NASDAQ:SERV traded up $0.30 during mid-day trading on Monday, hitting $3.52. 8,428,967 shares of the stock traded hands, compared to its average volume of 4,495,794. The business's 50-day moving average price is $3.96 and its 200 day moving average price is $7.02. The company has a market cap of $305.65 million, a PE ratio of -1.36 and a beta of 1.92. Serve Robotics has a 12-month low of $2.26 and a 12-month high of $16.08.
Read Our Latest Research Report on SERV
MDA Space (MDA)
MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure.
MDA Space stock traded up $2.37 during midday trading on Monday, reaching $30.77. 574,675 shares of the stock were exchanged, compared to its average volume of 1,324,402. MDA Space has a 52 week low of $23.23 and a 52 week high of $49.37. The company has a debt-to-equity ratio of 0.31, a quick ratio of 2.07 and a current ratio of 2.10. The firm has a market cap of $4.99 billion and a PE ratio of 56.98. The company's fifty day moving average is $28.91 and its 200-day moving average is $33.22.
Read Our Latest Research Report on MDA
PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
NASDAQ:PRCT traded up $1.76 during trading hours on Monday, hitting $22.38. The stock had a trading volume of 605,763 shares, compared to its average volume of 1,507,031. The company has a 50 day simple moving average of $19.32 and a two-hundred day simple moving average of $23.13. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of -11.08 and a beta of 0.88. The company has a debt-to-equity ratio of 0.16, a current ratio of 5.89 and a quick ratio of 4.73. PROCEPT BioRobotics has a one year low of $16.67 and a one year high of $38.11.
Read Our Latest Research Report on PRCT
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.